We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Program Designed to Provide High-Performance Computing Cluster Systems for Bioinformatics Research

By LabMedica International staff writers
Posted on 25 Jan 2015
Print article
Dedicated Computing (Waukesha, WI, USA), a global technology company, reported that it will be participating in the Intel Cluster Ready program to deliver integrated high-performance computing cluster solutions to the life sciences market.

Powered by Intel Xeon processors, Dedicated Computing is providing a range of purpose-built analytics and storage clusters for use in bioinformatics research. Dedicated Computing’s HPC cluster, built upon Intel Cluster Ready architecture, will provide a fully integrated and optimized cluster.

From entry level, compact clusters, featuring four multi-core homogeneous nodes, to those with hundreds of heterogeneous computing nodes, and combined with 20 Terabytes to multiple Petabytes of object store, these scalable solutions will be able to support the massive amounts of data that needs to be analyzed, interpreted, and stored. These integrated cluster solutions contain securely maintained open source software stacks and cluster management that are designed to accelerate time-to-market, minimize expensive validation and verification and enable 24 x 7-hour x 365-day system monitoring for increased uptime.

“We are excited to join the Intel Cluster Ready program—working together, we can deliver leading edge HPC clustering technology tailored to Life Sciences research applications like genome analysis that will soon lead to personalized medicine,” said Jeff Durst, director, healthcare and life science solutions, Dedicated Computing. “Our healthcare expertise and design capabilities help support the needs of our customers with flexible and innovative technology.”

“Participation in the Intel Cluster Ready program makes it easier and faster to realize the performance advantages of HPC clusters,” said Stephen Wheat, Sr. director for HPC systems solutions at Intel. “The assurance of application and component interoperability from the moment a cluster powers on is critical in the markets Dedicated Computing serves. We are excited to have Dedicated Computing join the program and look forward to working with them to help advance research and drive innovation in the Life Sciences market.”

Related Links:

Dedicated Computing
Intel Cluster Ready


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.